Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway. The gene discussed is CXCR4; the disease is B-cell chronic lymphocytic leukemia.